Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our growing team in Heidelberg, Germany, we are looking for a
(Reference No. R2005)
to support preclinical and clinical development of novel biologics in immuno-oncology.